. Author manuscript; available in PMC: 2021 Nov 1.

Published in final edited form as: Ann Intern Med. 2021 Jan 26;174(5):703–704. doi: 10.7326/M21-0367

TABLE:

Adjusted odds ratios for adverse COVID-19 outcomes in patients with type 1 and type 2 diabetes.

Outcome	Population Analyzed	Number of patients analyzed (No Diabetes vs T1DM vs. T2DM)	Adjusted O.R. T1DM vs. No Diabetes	Adjusted O.R. T2DM vs. No Diabetes
Mortality^*(5)	England, March 1-May 11, 2020	58,244,220 vs. 263,830 vs. 2,864,670	3.51 (3.16–3.90)	2.03 (1.97–2.09)
Mortality or ICU admission^†(8)	Scotland, March 1-July 31, 2020	5,143,951 vs. 34,383 vs. 275,960	2.40 (1.82–3.16)	1.37 (1.28–1.47)
Hospitalization^‡	Vanderbilt Health System, March 17-December 24, 2020	19,422 vs. 136 vs. 1,100	4.60 (3.04–6.98)	3.42 (2.94–3.99)
1^st HbA1c quartile		19,422 vs. 26	2.96 (1.11–7.86)
2^nd HbA1c quartile		19,422 vs. 26	2.96 (1.11–7.86)
3^rd HbA1c quartile		19,422 vs. 24	5.12 (2.12–12.35)
4^th HbA1c quartile		19,422 vs. 25	9.76 (4.42–21.54)

Adjusted for age, sex, deprivation index, ethnicity, and geographical region.

^†

Adjusted for age and sex.

^‡

Adjusted for age, race, sex, hypertension, smoking, and BMI.